Ideaya’s late-stage data for a rare eye cancer drug has passed the company’s benchmark for success, bolstering expectations for a planned accelerated filing in the US.
The open-label Phase 2/3 uveal melanoma trial tested the …
Bain Capital is implementing a blueprint that’s worked before, officially launching a company Wednesday with five assets from Bristol Myers Squibb. The biotech will be
Amazon has pitched an AI-powered drug discovery platform to the biopharma industry that combines in silico and wet-lab work in a single application.
The FDA has laid out Lilly’s post-marketing safety testing requirements for Lilly’s weight-loss pill Foundayo, including clinical trials.
The FDA is concerned that Eli Lilly’s newly approved obesity pill Foundayo might come with a risk for major cardiovascular events and liver damage, and
Replimune’s second complete response letter for its cancer therapy last week is already leading to multiple rounds of layoffs and existential questions about the company’s
Ideaya’s late-stage data for a rare eye cancer drug has passed the company’s benchmark for success, bolstering expectations for a planned accelerated filing in the US.
The open-label Phase 2/3 uveal melanoma trial tested the …